Confidence In Factor XIa Inhibition Wavers After Bristol/Janssen And Bayer Data

High Expectations For Next Big Oral Anticoagulant Drug Class

Red question mark on a background of black question marks
Phase II trials left several unanswered questions for milvexian and asundexian • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D